Evidence map›Paper›PMID 42751290›Full record

ArticleAnnals of the Child Neurology Society2026

Retrospective Analysis of T2-Hyperintense Lesions in Children With Neurofibromatosis Type 1.

Ariel B Brickler, Manu S Goyal, Robert C McKinstry, David H Gutmann, Jennifer L Griffith

Abstract read
In one paragraph

Article in Annals of the Child Neurology Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ariel B BricklerDepartment of Neurology Washington University School of Medicine St. Louis Missouri USA.
Manu S GoyalDepartment of Radiology Washington University School of Medicine St. Louis Missouri USA.
Robert C McKinstryDepartment of Radiology Washington University School of Medicine St. Louis Missouri USA.
David H GutmannDepartment of Neurology Washington University School of Medicine St. Louis Missouri USA.ORCID https://orcid.org/0000-0002-3127-5045
Jennifer L GriffithDepartment of Neurology Washington University School of Medicine St. Louis Missouri USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study is to determine whether a previously reported three-tiered classification scheme for T2-hyperintense brain lesions in children with neurofibromatosis type 1 (NF1) was associated with distinct radiographic or clinical characteristics after 10 years of real-world follow-up data were obtained. Methods: In this single-center retrospective study, we analyzed T2-hyperintense lesions identified on brain magnetic resonance imaging (MRI) of 58 children with NF1. Lesions were categorized as "Low Likelihood of Tumor," "Intermediate Likelihood of Tumor," or "High Likelihood of Tumor" using predefined imaging criteria adopted by our institution. Clinical and radiologic data were evaluated with generalized estimating equations (GEEs). Results: No demographic variables were associated with lesion category, apart from small age differences and a lower proportion of "High Likelihood of Tumor" lesions occurring in males compared with "Low Likelihood of Tumor." Localization patterns differed modestly, but anatomic site was not associated with radiographic evolution or treatment. Most lesions initially classified as "Low Likelihood of Tumor" or "Intermediate Likelihood of Tumor" remained stable or resolved, and none required therapy. Even among lesions initially classified as "High Likelihood of Tumor," only a small subset required treatment, most often those demonstrating pronounced T1 hypointensity. Interpretation: NF1-associated T2-hyperintense lesions demonstrate substantial overlap in clinical and radiographic characteristics, particularly those classified as "Low Likelihood of Tumor" and "Intermediate Likelihood of Tumor," while generally following a benign course. Features such as lesion location, enhancement, or mass effect are not consistently associated with treatment. These findings support close monitoring of lesions classified as "High Likelihood of Tumor" with pronounced T1 hypointensity.

Indexed as

focal areas of signal intensitygliomaNF1optic pathway gliomaT2 hyperintensity

Identifiers

PMID42751290
PMCPMC13580337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.